Article // Intelligence
Investment Ideas by Antonio · Jul 10, 2026
They Were Paralyzed. Then They Joined a Peptide Trial.
Participants from NervGen's latest trial tell their own stories.
What's interesting
Engagement
Likes: 32
Comments: 5
Restacks: 1
Entities
Sponsorship
No sponsorship detected
Related articles
NervGen: Chasing Ozempic for the Nervous System.
Investment Ideas by Antonio · Spinal cord injury · biotech investing · NVG-291
NervGen's Future.
Investment Ideas by Antonio · Spinal cord injury · NVG-291 · NervGen
IREN: The Asymmetry Widens
Investment Ideas by Antonio · Antonio Linares · Same publication
Stretch Marks 8-27-26
Stretch Marks by Melissa Radke · peptide therapy
the loewe of telehealth is a peptide company
as seen on · peptide therapy
🤑 This simple website made $240K in 10 days, He’s making $108K/year from one tiny tool & $60K in month 3 from a skill he picked up on YouTube.
Venture Radar · clinical trials
Parky Profile: Andy Cassy
Rory’s Always On Newsletter · clinical trials
BARDA Puts $80 Million-Plus Behind New H5N1 ‘Bird Flu’ Vaccines Before Any Pandemic
JonFleetwood.com · clinical trials